Acute bronchitis primary prevention: Difference between revisions
Jump to navigation
Jump to search
(Created page with "{{Acute bronchitis}} {{CMG}} ==Overview== Onset can be mitigated through various prevention methodologies. Vaccinations serve to as an effective mechanism for primary prevention...") |
m (Robot: Changing Category:Disease state to Category:Disease) |
||
| Line 10: | Line 10: | ||
== References == | == References == | ||
{{reflist|2}} | {{reflist|2}} | ||
[[fr:Bronchite]] | [[fr:Bronchite]] | ||
[[ja:気管支炎]] | [[ja:気管支炎]] | ||
| Line 27: | Line 19: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Inflammations]] | |||
[[Category:Pulmonology]] | |||
[[Category:General practice]] | |||
[[Category:Disease]] | |||
[[Category:Mature chapter]] | |||
Revision as of 18:42, 9 December 2011
|
Acute bronchitis Microchapters |
|
Diagnosis |
|
Treatment |
|
Acute bronchitis primary prevention On the Web |
|
American Roentgen Ray Society Images of Acute bronchitis primary prevention |
|
Risk calculators and risk factors for Acute bronchitis primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Onset can be mitigated through various prevention methodologies. Vaccinations serve to as an effective mechanism for primary prevention.
Prevention
In 1985, University of Newcastle, Australia Professor Robert Clancy developed an oral vaccine for acute bronchitis. This vaccine was commercialized four years later as Broncostat.[1]
References
- ↑ Broncostat. Biotechnology.com. Retrieved on October 3 2007.